Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 33, 2016 - Issue 9
158
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Circadian variation of cytotoxicity and genotoxicity induced by an immunosuppressive agent “Mycophenolate Mofetil” in rats

, , , , , , , , & show all
Pages 1208-1221 | Received 18 Apr 2016, Accepted 06 Jul 2016, Published online: 02 Aug 2016

References

  • Adams E, Todd G, Gibson W. (1975). Long-term toxicity study of mycophenolic acid in rabbits. Toxicol Appl Pharmacol. 4:509–12.
  • Adeoye GO, Alimba CG, Oyeleke OB. (2015). The genotoxicity and systemic toxicity of a pharmaceutical effluent in Wistar rats may involve oxidative stress induction. Toxicol Rep. 2:1265–72.
  • Allison AC, Eugui EM. (2000). Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 47:85–118.
  • Allison A, Eugui EM. (2005). Mechanisms of action of mycophenolate mofetil activity. Biochernistry. 3:3896–901.
  • Apel H, Walschburger-Zorn K, Häberle L, et al. (2013). De novo malignancies in renal transplant recipients: Experience at a single center with 1882 transplant patients over 39 yr. Clin Transplant. 27:E30–6.
  • Ben-Cherif W, Dridi I, Aouam K, et al. (2014a). Circadian variation of valproic acid pharmacokinetics in mice. Eur J Pharm Sci. 49:468–73.
  • Ben-Cherif W, Dridi I, Hassine M, et al. (2014b). Circadian haematotoxicity of the antiepileptic valproic acid in mice. J Appl Biomed. 12:31–8
  • Berger J. (2008). Advances in chronohaematology. J Appl Biomed. 6:65–72.
  • Bhilwade HN, Jayakumar S, Chaubey RC. (2014). Age-dependent changes in spontaneous frequency of micronucleated erythrocytes in bone marrow and DNA damage in peripheral blood of Swiss mice. Mutat Res Genet Toxicol Environ Mutagen. 770:80–4.
  • Bullingham RE, Nicholls AJ, Kamm BR. (1998). Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet. 34:429–55.
  • Cilião L, Ribeiroa DL, Camargo-Godoyb RBO, et al. (2015). Cytotoxic and genotoxic effects of high concentrations of the immunosuppressive drugs cyclosporine and tacrolimus in MRC-5 cellsH. Exp Toxicol Pathol. 67:179–87.
  • Chaubey RC, Bhilwade HN, Rajagopalan R, Bannur SV. (2001). Gamma ray induced DNA damage in human and mouse leucocytes measured by SCGE-Pro: Asoftware developed for automated image analysis and data processing for comet assay. Mutat Res. 490:187–97.
  • Christophejer M M, White G, Eaton J W. (1990). Erythrocyte pathology and mechanisms of heinz body-mediated hemolysis in cats. Vet Pathol. 27:299–310.
  • Cusinato DA, Lacchini R, Romao EA, et al. (2014). Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients. Br J Clin Pharmacol. 78:364–72.
  • Danesi R, Del Tacca M. (2004). Hematologic toxicity of immunosuppressive treatment. Transplant Proc. 36:703–4.
  • De Franceschi L, Olivieri O, Corrocher R. (2004). Erythrocyte aging in neurodegenerative disorders. Cell Mol Biol. 50:179–85.
  • Dridi I, Ben-Cherif W, Haouas Z, et al. (2015). Gastrointestinal toxicity of mycophenolate mofetil in rats: Effect of administration time. Chronobiol Int. 32:1373–84.
  • Dridi I, Ben-Cherif W, Aouam K, et al. (2014). Circadian variation of mycophenolate mofetil pharmacokinetics in rats. Eur J Pharm Sci. 58:20–5.
  • Dridi I, Ben-Cherif W, Aouam K, et al. (2012). Murine circadian time-dependent tolerance to the immunosuppressive agent mycophenolate mofetil (MMF). Biol Rhythm Res. 1–9, iFirst article.
  • EBPG Expert Group on Renal Transplantation. (2002a). European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.1. Anaemia. Nephrol Dial Transplant. 17:48.
  • EBPG Expert Group on Renal Transplantation. (2002b). European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.2. Leukopenia. Nephrol Dial Transplant. 17:49.
  • Eugui EM, Almquist SJ, Muller CD, Allison AC. (1991). Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: Role of deoxyguanosine nucleotide depletion. Scand J Immunol. 33:161–73.
  • Fenneteau O, Hurtaud-Roux MF, Schlegel N. (2006). Normal and abnormal cytological aspects of peripheral blood cells in neonates and young children. Ann Biol Clin. 64:17–36.
  • Fulton B, Markham A. (1996). Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs. 51:278–98.
  • Giaccone L, McCune JS, Maris MB, et al. (2005). Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation. Blood. 106:4381–88.
  • Grissa I, Elghoul J, Ezzi L, et al. (2015). Anemia and genotoxicity induced by sub-chronic intragastric treatment of rats with titanium dioxide nanoparticles. Mutat Res Genet Toxicol Environ Mutagen. 794:25–31.
  • Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. (2004). Cancer after kidney transplantation in the United States. Am J Transplant. 4:905–13.
  • Knops N, Levtchenko E, van den Heuvel B, Kuypers D. (2013). From gut to kidney: Transporting and metabolizing calcineurin-inhibitors in solid organ transplantation. Int J Pharm. 452:14–35.
  • Kobayashi H, Sugiyama C, Morikawa Y, et al. (1995). A comparison betweenmanual microscopic analysis and computerized image analysis in the single cellgel electrophoresis assay. MMS Commun. 3:103–15.
  • Krishna G, Hayashi M. (2000). In vivo rodent micronucleus assay: Protocol, conductand data interpretation, Mutat Res. 455:155–66.
  • Levi F, Horvath C, Mechkouri M, et al. (1987). Circadian time dependence of murine tolerance for the alkylating agent peptichemio. Eur J Cancer Clin Oncol. 23:487–97.
  • Lévi F, Karaboué A, Gorden L, et al. (2011). Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): Safety, efficacy and improved secondary surgical resectability. Cancer Chemother Pharmacol. 67:339–48.
  • Lévi F, Dugué PA, Innominato P, et al. (2014). Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival. Chronobiol Int. 31:891–900.
  • Mackie F, Verran D, Horvath J, Tiller D. (1996). Severe thrombocytopenia with OKT3 use for steroid-resistant rejection in a cadaveric renal transplant recipient. Nephrol Dial Transplant. 11:2378.
  • Manoharan K, Banerjee MR. (1985). beta-Carotene reduces sister chromatid exchangesinduced by chemical carcinogens in mouse mammary cells in organ culture. Cell Biol Int Rep. 9:783–9.
  • Mårtensson L, Nilsson R, Ohlsson T,et al. (2010). Tennvall J.,High-dose radioimmunotherapy combined with extracorporeal depletion in asyngeneic rat tumor model: Evaluation of toxicity, therapeutic effect, and tumor mode. Cancer. 116:1043–52.
  • Morris RG. (2003). Cyclosporin therapeutic drug monitoring–an established service revisited. Clin Biochem Rev. 24:33–46.
  • Mycophenolate mofetil. PrCellCept®, Product Monograph. Available from: Revision 2016 http://www.rochecanada.com
  • Nelson W, Tong YL, Lee JK, Halberg F. (1979). Methods for cosinor rhythmometry. Chronobiologia. 6:305–23.
  • Oliveira VD, Zankl H, Rath T. (2004). Mutagenic and cytotoxic effects of immunosuppressivedrugs on human lymphocyte cultures. Exp Clin Transplant. 2:273–82.
  • Oztürk S, Ayna TK, Cefle K,et al. (2008). Effect of cyclosporin A and tacrolimus on sister chromatid exchange frequency in renal transplant patients. Genet Test. 12:427–30.
  • Pally C, Tanner M, Rizvi H, et al. (2001). Tolerability profile of sodium mycophenolate (ERL080) and mycophenolate mofetil with and without cyclosporine (Neoral) in the rat. Toxicology. 157:207–15.
  • Ponticelli C, Cucchiari D, Bencini P. (2014). Skin cancer in kidney transplant recipients. J Nephrol. 27:385–94.
  • Refinetti R, Lissen GC, Halberg F. (2007). Procedures for numerical analysis of circadian rhythms. Biol Rhythm Res. 38:275–325.
  • Reinberg AE. (1992). Concepts in chronopharmacology. Annu Rev Pharmacol Toxicol. 32:51–66.
  • Reinberg A, Ashkenazi I. (2003). Concepts in human biological rhythms. Dialogues Clin Neurosci. 5:327–42.
  • Sandhya T, Lathika KM, Pandey BN, et al. (2006). Protection against radiation oxidative damage inmice by triphala. Mutat. Res. 609:17–25.
  • Shaw LM, Holt DW, Oellerich M, et al. (2001). Current issues in therapeutic drug monitoring of mycophenolic acid: Report of a roundtable discussion. Ther Drug Monit. 23:305–15.
  • Shaw LM, Korecka M, Venkataramanan R, et al. (2003). Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant. 3:534–42.
  • Simmons WD, Rayhill SC, Sollinger HW. (1997). Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection. Drug Saf. 17:75–92.
  • Singh NP, McCoy MT, Tice RR, Schneider EL. (1988). A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 175:184–191.
  • Smolensky MH, Peppas NA. (2007). Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 59:828–51.
  • Smolensky MH, D’alonzo GE. (1993). Medical chronobiology: Concepts and applications. Am Rev Respir Dis. 147:S2–19.
  • Sobiak J, Kamińska J, Głyda M, et al. (2013). Effect of mycophenolate mofetil on hematological side effects incidence in renal transplant recipients. Clin Transplant. 27:E407–14.
  • Srinivas TR, Meier-Kriesche HU, Kaplan B. (2005). Pharmacokinetic principles of immunosuppressive drugs. Am J Transplant. 5: 207–17.
  • Taylor AL, Watson CJ, Bradley JA. (2005). Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol. 56:23–46.
  • Therrien R, Sastre T. (2008). Pharmacocinétique du mofétilmycophénolate en greffe hématopoïétique: étude d’un cas pédiatrique. Pharmactuel. 41:94–8.
  • Touitou Y, Portaluppi F, Smolensky MH, Rensing L. (2004). Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol Int. 21:161–70.
  • Virji M, Carter JE, Lirenman DS. (2001). Single-center experience with mycophenolate mofetil in pediatric renal transplant recipients. Pediatr Transplant. 5:293–6.
  • von Ledebur M, Schmid W. (1973). The micronucleus test. Methodological aspects,Mutat. Res. 19:109–17.
  • Xiao Z, Li C, Shan J, et al. (2011). Mechanisms of renal cell apoptosis induced by cyclosporine A: A systematic review of in vitro studies. Am J Nephrol. 33:558–66.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.